Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GLIDE Gel
- Development stage
- Unknown
- Lead developer
- BOHECO
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
GLIDE Gel (also marketed as GLIDE+ Gel) is a topical Ayurvedic emulgel developed by BOHECO (Bombay Hemp Company) for the relief of arthritis, joint pain, and osteoarthritis. The formulation features a 3X concentration of Cannabis Leaf Extract (Vijaya Leaf Extract), providing full-spectrum cannabinoids that interact with the body's endocannabinoid system via cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) to modulate pain signaling and inflammatory pathways. It also contains Shallaki (Boswellia serrata) resin extract, Hemp Seed Oil, and other botanical ingredients that contribute anti-inflammatory, analgesic, and joint-lubricating properties. Delivered via Advanced Emulgel Technology, the product offers rapid absorption and incorporates therapeutic heat actives to alleviate joint stiffness and improve mobility during flare-ups.
- Brand names
- GLIDE GelGLIDE+ Gel
- Other names
- BOHECO GLIDE GelBOHECO GLIDE+ GelGLIDEGLIDE+ Emulgel
02
Targets
ALOX5 (Arachidonate 5-lipoxygenase)CNR1 (Cannabinoid receptor 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on GLIDE Gel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GLIDE Gel.